Literature DB >> 34418441

Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.

Palanisamy Nallasamy1, Rama Krishna Nimmakayala1, Saswati Karmakar1, Frank Leon1, Parthasarathy Seshacharyulu1, Imayavaramban Lakshmanan1, Satyanarayana Rachagani1, Kavita Mallya1, Chunmeng Zhang2, Quan P Ly2, Molly S Myers1, Lindenberger Josh1, Corinn E Grabow1, Shailendra K Gautam1, Sushil Kumar1, Subodh M Lele3, Maneesh Jain4, Surinder K Batra5, Moorthy P Ponnusamy6.   

Abstract

BACKGROUND & AIMS: Tumor-microenvironment factors and cancer stem cells (CSCs) play a critical role in the aggressiveness of pancreatic cancer (PC). However, the degree to which tumor-microenvironment factors promote stemness remains unexplored. Here, we examined whether cancer-associated fibroblasts (CAFs) promote CSC features in PC.
METHODS: PC cells were treated long-term (30, 60, and 90 days) with conditioned media (CM)-derived from normal human fibroblasts (NFs) and CAFs. The stemness features of tumorsphere formation and stemness populations, along with CSCs markers, were analyzed using 2-dimensional and 3-dimensional sodium alginate bead-based co-culture models. Immunohistochemistry and immunofluorescence staining were performed for CSCs and fibroblast markers in autochthonous KrasG12D/+; Trp53R172H/+; Pdx1-Cre mice and human pancreatic tumors. Polymerase chain reaction array and gene knockdown were performed to identify the mechanism of stemness enrichment.
RESULTS: Long-term treatment of PC cells with CAF-CM enriched stemness, as indicated by significantly higher CD44+, ALDH+, and AF+ populations in PC cells. Increased tumorsphere formation and elevated CSC, self-renewal, and drug-resistance markers in CAF-CM-treated PC cells were observed. In addition, CAFs co-cultured with PC cells in the 3-dimensional model showed a substantial increase in stemness features. CD44 and α-smooth muscle actin were positively correlated and their expressions progressively increased from the early to late stages of KrasG12D/+; Trp53R172H/+; Pdx1-Cre mouse and human pancreatic tumors. Osteopontin/secreted phosphoprotein 1 was identified as the top differentially overexpressed gene in CAF-CM-treated PC cells and knockdown of osteopontin/secreted phosphoprotein 1 significantly reduced stemness characteristics in CAF-CM-treated PC cells.
CONCLUSIONS: Our data uncovered novel insight into the interplay between CAF and enrichment of stemness population through the osteopontin/secreted phosphoprotein 1-CD44 axis in PC. Published by Elsevier Inc.

Entities:  

Keywords:  CD44; Cancer Stem Cells; Cancer-Associated Fibroblast; OPN/SPP1; Pancreatic Cancer

Mesh:

Substances:

Year:  2021        PMID: 34418441     DOI: 10.1053/j.gastro.2021.08.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.

Authors:  Meilin Qu; Tao Han; Xiaoquan Chen; Qingqing Sun; Qing Li; Mingfang Zhao
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system.

Authors:  Sebastian Schuth; Solange Le Blanc; Teresa G Krieger; Julia Jabs; Christian Conrad; Oliver Strobel; Miriam Schenk; Nathalia A Giese; Markus W Büchler; Roland Eils
Journal:  J Exp Clin Cancer Res       Date:  2022-10-22

3.  Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.

Authors:  Imayavaramban Lakshmanan; Saravanakumar Marimuthu; Sanjib Chaudhary; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Sakthivel Muniyan; Ramakanth Chirravuri-Venkata; Pranita Atri; Sanchita Rauth; Rama Krishna Nimmakayala; Jawed Akhtar Siddiqui; Shailendra K Gautam; Ashu Shah; Gopalakrishnan Natarajan; Seema Parte; Namita Bhyravbhatla; Kavita Mallya; Dhanya Haridas; Geoffrey A Talmon; Lynette M Smith; Sushil Kumar; Apar Kishor Ganti; Maneesh Jain; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Oncogene       Date:  2022-10-21       Impact factor: 8.756

4.  Pan-cancer analysis of oncogenic role of Programmed Cell Death 2 Like (PDCD2L) and validation in colorectal cancer.

Authors:  Huabin Gao; Cheng Xu; Jiangtao Liang; Songhan Ge; Fenfen Zhang; Ying Tuo; Huijuan Shi; Anjia Han
Journal:  Cancer Cell Int       Date:  2022-02-25       Impact factor: 5.722

5.  The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC.

Authors:  Zhi Wang; Lingling Zhang; Wenwen Xu; Jie Li; Yi Liu; Xiaozhu Zeng; Maoxi Zhong; Yuxi Zhu
Journal:  J Inflamm Res       Date:  2022-02-02

6.  Digital Spatial Profiling of Individual Glomeruli From Patients With Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.

Authors:  Lin Ye; Yu Liu; Xuejing Zhu; Tongyue Duan; Chang Wang; Xiao Fu; Panai Song; Shuguang Yuan; Hong Liu; Lin Sun; Fuyou Liu; Kyung Lee; John Cijiang He; Anqun Chen
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 7.  Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.

Authors:  Yongsheng Ruan; Libai Chen; Danfeng Xie; Tingting Luo; Yiqi Xu; Tao Ye; Xiaona Chen; Xiaoqin Feng; Xuedong Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

Review 8.  The Role of Adipokines in Pancreatic Cancer.

Authors:  Qi Wang; Huizhi Wang; Yuntao Ding; Mengtian Wan; Min Xu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

9.  Single-Cell RNA Sequencing Unravels Distinct Tumor Microenvironment of Different Components of Lung Adenocarcinoma Featured as Mixed Ground-Glass Opacity.

Authors:  Yu He; Fenglei Yu; Yi Tian; Qikang Hu; Bin Wang; Li Wang; Yan Hu; Yongguang Tao; Xiaofeng Chen; Muyun Peng
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 10.  Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.

Authors:  Yongquan Tang; Yan Chen; Zhe Zhang; Bo Tang; Zongguang Zhou; Haining Chen
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.